Tresiba® New Once Daily Insulin Launched in Malta
{module [592]} {mp4remote}/images/ts-images/videos/technoline/kerrapro.mp4{/mp4remote}
In December 2014 Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for expanded use of Tresiba® (insulin degludec) in children and adolescents aged 1-17 years with diabetes. And now, after the approval of the European…
Poor glucose control in patients with diabetes can ultimately result in diabetic complications that can bedevastating for the patient’s quality of life, life-shortening, and expensive to treat for national healthcare systems.Current expert guidelines on the treatment of type 2 diabetes therefore advocate the addition of…
Recommendation is based on the RECOURSE study results demonstrating survival advantage for patients with refractory disease
Click to read the SPC
RIGID Ultrasound Gel 5Ltr, with one bag our clients get the second one half price, i.e. they save nearly Eur 9 (total) and each bag will cost Eur 13.40 instead of Eur 17.87 . Offer is valid until stock lasts and includes delivery.